Joanne Mann
UCB Pharma (United Kingdom)(GB)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Pancreatic and Hepatic Oncology Research, Cancer Cells and Metastasis, Cannabis and Cannabinoid Research, Psoriasis: Treatment and Pathogenesis
Most-Cited Works
- → Proof‐of‐Concept Study to Assess the Nociceptin Receptor Antagonist LY2940094 as a New Treatment for Alcohol Dependence(2016)42 cited
- → Seletalisib for Activated PI3Kδ Syndromes: Open-Label Phase 1b and Extension Studies(2020)32 cited
- → Fire Risk Prediction Using Multi-Source Data: A case study in Humberside area(2019)11 cited
- → Abstract CT094: Phase I dose-escalation study evaluating the safety and tolerability of ginisortamab (UCB6114), a first-in-class anti-gremlin-1 monoclonal antibody (mAb), as monotherapy in advanced solid tumors(2023)6 cited
- → Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exploratory study with PET-CT imaging(2024)3 cited
- → Table of contents(2019)
- → Why do common sense trials fail in the UK? Lessons learned from a trial which tested the effectiveness and cost-effectiveness of a community falls prevention programme (the Firefli study)(2025)
- → Abstract CT156: Phase 1 dose-optimization study evaluating the safety of ginisortamab (UCB6114), an anti-gremlin-1 monoclonal antibody (mAb) with first-in-class potential, as monotherapy in advanced solid tumors(2025)